Načítá se...
Improved adjuvant endocrine therapy for premenopausal women with endocrine responsive disease
Results from two randomised global trials (SOFT & TEXT) designed to newly define the most effective components of adjuvant endocrine therapy for premenopausal women with endocrine responsive disease, showed that for some, those with high risk of relapse, the use of the aromatase inhibitor exemes...
Uloženo v:
| Vydáno v: | Ecancermedicalscience |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Cancer Intelligence
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4462884/ https://ncbi.nlm.nih.gov/pubmed/26082801 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3332/ecancer.2015.544 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|